Rebecca Strafella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rebecca Strafella has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Richard Wang
School of Medicine New York Medical College Valhalla New York USA
2 shared publications - Ariel Sacknovitz
New York Medical College
1 shared publication - Ariel Sacknovitz
School of Medicine, New York Medical College, Valhalla, NY 10595, USA
1 shared publication Avinash Mohan
Department of Neurosurgery, Westchester Medical Center, Valhalla, New York
1 shared publicationCamarin E. Rolle
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA, USA
1 shared publication- Carolyn Robb
New York Medical College School of Medicine, Valhalla, USA
1 shared publication
Latest Publications
- Open Access
- 5 May 2026
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 313 (1)
Severe maternal morbidity in patients of advanced maternal age with and without metabolic syndrome
Purpose: To estimate the burden of metabolic syndrome (MetS) on severe maternal morbidity (SMM) in women of advanced maternal age (AMA), quantify age-related escalation in SMM risk, and evaluate sociodemographic influences. Methods: We retrospectively conducted a cross-sectional, population-level analysis of the Nationwide Inpatient Sample (Q4 2015–2019), a discharge-level database, to identify delivery hospitalizations among patients aged ≥ 35 years. MetS was defined by ICD-10 codes indicating ≥ 3 of the following: hypertension, type 2 diabetes, obesity, hypertriglyceridemia, or low high-density lipoprotein cholesterol. The primary outcome was SMM as defined by the Centers for Disease Control and Prevention; a secondary outcome excluded blood transfusion. Multivariable logistic regression adjusted for race, income quartile, primary payer, hospital characteristics, and substance use. Weighted adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were reported. Results: Among 3.1 million delivery hospitalizations, 556,609 (17.8%) occurred in AMA patients; 12,188 (2.2%) experienced SMM and 6,528 (1.2%) experienced nontransfusion SMM. SMM was significantly higher among patients with MetS compared to those without (7.37% vs 2.17%; nontransfusion SMM: 5.36% vs 1.16%). SMM rates increased with advancing age. After adjustment, MetS was associated with markedly increased odds of SMM (AOR 2.75, 95% CI 2.29–3.30) and nontransfusion SMM (AOR 3.59, 95% CI 2.90–4.44), both p < 0.001. Conclusion: MetS is associated with SMM risk among AMA patients, independent of sociodemographic factors, with risk increasing further at older maternal ages. This study quantifies the disproportionate burden of MetS in this high-risk population.
- 5 May 2026
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 313 (1)
Open AccessSevere maternal morbidity in patients of advanced maternal age with and without metabolic syndrome
Purpose: To estimate the burden of metabolic syndrome (MetS) on severe maternal morbidity (SMM) in women of advanced maternal age (AMA), quantify age-related escalation in SMM risk, and evaluate sociodemographic influences. Methods: We retrospectively conducted a cross-sectional, population-level analysis of the Nationwide Inpatient Sample (Q4 2015–2019), a discharge-level database, to identify delivery hospitalizations among patients aged ≥ 35 years. MetS was defined by ICD-10 codes indicating ≥ 3 of the following: hypertension, type 2 diabetes, obesity, hypertriglyceridemia, or low high-density lipoprotein cholesterol. The primary outcome was SMM as defined by the Centers for Disease Control and Prevention; a secondary outcome excluded blood transfusion. Multivariable logistic regression adjusted for race, income quartile, primary payer, hospital characteristics, and substance use. Weighted adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were reported. Results: Among 3.1 million delivery hospitalizations, 556,609 (17.8%) occurred in AMA patients; 12,188 (2.2%) experienced SMM and 6,528 (1.2%) experienced nontransfusion SMM. SMM was significantly higher among patients with MetS compared to those without (7.37% vs 2.17%; nontransfusion SMM: 5.36% vs 1.16%). SMM rates increased with advancing age. After adjustment, MetS was associated with markedly increased odds of SMM (AOR 2.75, 95% CI 2.29–3.30) and nontransfusion SMM (AOR 3.59, 95% CI 2.90–4.44), both p < 0.001. Conclusion: MetS is associated with SMM risk among AMA patients, independent of sociodemographic factors, with risk increasing further at older maternal ages. This study quantifies the disproportionate burden of MetS in this high-risk population.
- Open Access
Excitation-Inhibition Balance and Fronto-Limbic Connectivity Drive TMS Treatment Outcomes in Refractory Depression
Depression affects over 350 million people worldwide, with treatment resistance occurring in up to 30% of cases. Intermittent theta burst stimulation (iTBS) targeting the left dorsolateral prefrontal cortex (DLPFC) has emerged as a promising intervention, yet the neurophysiological mechanisms determining which patients will respond remain poorly understood. Here, we combined transcranial magnetic stimulation with electroencephalography and whole-brain computational modeling to uncover the mechanistic basis of treatment efficacy in 90 patients with treatment-resistant depression. We identified two distinct neurophysiological signatures that differentiate responders from non-responders: (1) post-treatment shifts in excitation-inhibition balance toward greater inhibitory control, and (2) a pre-treatment brain state characterized by anticorrelated dynamics between subgenual anterior cingulate cortex and DLPFC. These features were significantly correlated with clinical improvement and could not be explained by non-specific factors. Our findings provide a neurophysiologically-informed framework for developing personalized and optimized neuromodulation approaches in treatment-resistant depression.
Open AccessExcitation-Inhibition Balance and Fronto-Limbic Connectivity Drive TMS Treatment Outcomes in Refractory Depression
Depression affects over 350 million people worldwide, with treatment resistance occurring in up to 30% of cases. Intermittent theta burst stimulation (iTBS) targeting the left dorsolateral prefrontal cortex (DLPFC) has emerged as a promising intervention, yet the neurophysiological mechanisms determining which patients will respond remain poorly understood. Here, we combined transcranial magnetic stimulation with electroencephalography and whole-brain computational modeling to uncover the mechanistic basis of treatment efficacy in 90 patients with treatment-resistant depression. We identified two distinct neurophysiological signatures that differentiate responders from non-responders: (1) post-treatment shifts in excitation-inhibition balance toward greater inhibitory control, and (2) a pre-treatment brain state characterized by anticorrelated dynamics between subgenual anterior cingulate cortex and DLPFC. These features were significantly correlated with clinical improvement and could not be explained by non-specific factors. Our findings provide a neurophysiologically-informed framework for developing personalized and optimized neuromodulation approaches in treatment-resistant depression.
- Open Access
- 14 April 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 9 (15)
Novel case of pediatric basal ganglia abscess due to Streptococcus intermedius amid a rise in neuroinvasive infections during the COVID-19 pandemic: illustrative case
BACKGROUND: Pediatric basal ganglia abscesses are extremely rare, with only 2 other published cases in the literature. To the authors’ knowledge, this is the first case of a primary bacterial abscess caused by Streptococcus intermedius in the basal ganglia of a pediatric patient. OBSERVATIONS: This case coincides with a rise in neuroinvasive streptococcal infections among children during the COVID-19 pandemic. Prompt MRI with diffusion and attenuation analyses allowed for abscess identification and treatment with neurosurgical drainage, leading to full recovery. Although intracranial abscesses in deep parenchymal locations are extremely rare in healthy children, the recently increased incidence of neuroinvasive infections and the devastating sequelae of delayed or missed diagnosis make early recognition and treatment essential. To this end, reporting and recognition of the varied presentations of this pathology is crucial. LESSONS: Herein, the authors highlight that in light of the surge in cases in recent years, patients suspected of having an intracranial abscess should not be delayed in receiving cranial imaging and treatment, as rapid identification and management of abscesses are crucial to reduce the likelihood of long-term complications. https://thejns.org/doi/10.3171/CASE24562
- 14 April 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 9 (15)
Open AccessNovel case of pediatric basal ganglia abscess due to Streptococcus intermedius amid a rise in neuroinvasive infections during the COVID-19 pandemic: illustrative case
BACKGROUND: Pediatric basal ganglia abscesses are extremely rare, with only 2 other published cases in the literature. To the authors’ knowledge, this is the first case of a primary bacterial abscess caused by Streptococcus intermedius in the basal ganglia of a pediatric patient. OBSERVATIONS: This case coincides with a rise in neuroinvasive streptococcal infections among children during the COVID-19 pandemic. Prompt MRI with diffusion and attenuation analyses allowed for abscess identification and treatment with neurosurgical drainage, leading to full recovery. Although intracranial abscesses in deep parenchymal locations are extremely rare in healthy children, the recently increased incidence of neuroinvasive infections and the devastating sequelae of delayed or missed diagnosis make early recognition and treatment essential. To this end, reporting and recognition of the varied presentations of this pathology is crucial. LESSONS: Herein, the authors highlight that in light of the surge in cases in recent years, patients suspected of having an intracranial abscess should not be delayed in receiving cranial imaging and treatment, as rapid identification and management of abscesses are crucial to reduce the likelihood of long-term complications. https://thejns.org/doi/10.3171/CASE24562
- Open Access
- 19 November 2024
- Published by Elsevier in Epilepsy & Behavior Reports
- Vol. 28, 100730
Resolution of Fenfluramine-associated pulmonary arterial hypertension in Lennox-Gastaut syndrome: A case report and literature review
- 19 November 2024
- Published by Elsevier in Epilepsy & Behavior Reports
- Vol. 28, 100730
Open AccessResolution of Fenfluramine-associated pulmonary arterial hypertension in Lennox-Gastaut syndrome: A case report and literature review